Comparing Omnipaque 300 vs Optiray 300
| Omnipaque 300 (iohexol) | Optiray 300 (ioversol) |
|
|---|
| Omnipaque 300 (iohexol) | Optiray 300 (ioversol) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Body Imaging, Aortography, Angiocardiography, Arthrography, Cerebral Arteriography, Cystourethrography, Digital Subtraction Angiography, Gastrointestinal Tract Examination, Head... View more |
Prescription only
Prescribed for Body Imaging, Cerebral Arteriography, Coronary Arteriography, Head Imaging, Intra-arterial Digital Subtraction Angiography, Intravenous Digital Subtraction Angiography, Intravenous... View more |
Related suggestions Body Imaging
Head Imaging
Visceral Arteriography
|
|||||||||||||||
| More about Omnipaque 300 (iohexol) | More about Optiray 300 (ioversol) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Omnipaque 300 has an average rating of 1.0 out of 10 from a total of 4 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Omnipaque 300 side effects |
View all Optiray 300 side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Omnipaque 300 prices |
View all Optiray 300 prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other iohexol brands include: Omnipaque 12, Omnipaque 140, Omnipaque 180, Omnipaque 180 Redi-Unit, Omnipaque 210, Omnipaque 240, Omnipaque 240 Redi-Unit, Omnipaque 350, Omnipaque 9, Omnipaque Flexipak, Oraltag View more | Other ioversol brands include: Optiray 240, Optiray 320, Optiray 350 | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
12 hours |
12 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 330 drugs are known to interact with Omnipaque 300:
|
A total of 150 drugs are known to interact with Optiray 300:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
|
|||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.